Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Jul 14, 2024
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The subjects of this study were patients with chronic cough who were admitted to the Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University from September 1, 2023 to December 31, 2024. Patients are registered if they meet all of the following criteria: (1) ≥18 years of age; (2) A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough;(3) Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared; (4) Chest X-ray and/or chest CT without significant evidence of lung...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥18 years old;
- • 2. A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough;
- • 3. Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared;
- • 4. Chest X-ray and/or chest CT without significant evidence of lung disease;
- • 5. No history of chronic cough (\>8 weeks) prior to COVID-19 infection.
- Exclusion Criteria:
- • 1. The patient refused pulmonary function and blood tests;
- • 2. The patient has previously been diagnosed with respiratory diseases with cough as one of the main symptoms, including cough variant asthma, allergic bronchitis, eosinophilic bronchitis, gastroesophageal reflux disease, chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis, interstitial lung disease, pulmonary/tracheobronchial tuberculosis, etc.;
- • 3. Patients who are pregnant or breastfeeding;
- • 4. The patient's medical records are incomplete;
- • 5. Patients lost to follow-up.
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Patients applied
Trial Officials
Juan Jiang, Doctor
Principal Investigator
Xiangya Hospital of Central South University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported